Ligation of CD11b and CD11c β2 integrins by antibodies or soluble CD23 induces macrophage inflammatory protein 1α (MIP-1α) and MIP-1β production in primary human monocytes through a pathway dependent on nuclear factor-κB

Blood

Volumn 97, Issue 10, 2001, Pages 2932-2940

  Rezzonico, Roger ^a,b   Imbert, Veronique ^a,b   Chicheportiche, Rachel ^a,b   Dayer, Jean Michel ^a,b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BETA2 INTEGRIN; CD11B ANTIGEN; CD23 ANTIGEN; GLYCOPROTEIN P 15095; HYBRID PROTEIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; PROTEASOME INHIBITOR;

ARTICLE; BINDING SITE; CYTOKINE PRODUCTION; DNA BINDING; ELECTROPHORETIC MOBILITY; GENE INDUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INFLAMMATION; INFLAMMATORY CELL; MONOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

EID: 0035874494     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.10.2932     Document Type: Article

References (88)

1. Taub DD. Chemokine-leukocyte interactions. Cytokine Growth Factor Rev. 1996;7:355-376.
2. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol. 1997;15:675-705.
3. Baggiolini M. Chemokines and leukocyte traffic. Nature. 1998;392:565-568.
4. Vaddi K, Newton RC. Comparison of biological responses of human monocytes and THP-1 cells to chemokines of the intercrine-β family. J Leukoc Biol. 1994;55:756-762.
5. Cross AK, Richardson V, Ali SA, et al. Migration responses of human monocytic cell lines to α-and β-chemokines. Cytokine. 1997;9:521-528.
6. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992;69:11-25.
7. Larson RS, Springer TA. Structure and function of leukocyte integrins. Immunol Rev. 1990;114:181-217.
8. Arnaout MA. Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood. 1990;75:1037-1050.
9. Van der Vieren M, Le Trong H, Wood CL, et al. A novel leukointegrin, αdβ2, binds preferentially to ICAM-3. Immunity. 1995;3:683-690.
10. Jiang Y, Beller DI, Frendl G, Graves DT. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol. 1992;148:2423-2428.
11. Vaddi K, Newton RC. Regulation of monocyte integrin expression by β-family chemokines. J Immunol. 1994;153:4721-4732.
12. Conklyn MJ, Neote K, Showell HJ. Chemokine-dependent up-regulation of CD11b on specific leukocyte subpopulations in human whole blood: effect of anticoagulant on RANTES and MIP-1β stimulation. Cytokine. 1996;8:762-766.
13. Landis RC, McDowall A, Holness HLL, et al. Involvement of the "I" domain of LFA-1 in selective binding to ligands ICAM-1 and ICAM-3. J Cell Biol. 1994;126:529-537.
14. Staunton DE, Dustin ML, Springer TA. Functional cloning of ICAM-2, a cell adhesion ligand for LFA-1 homologous to ICAM-1. Nature. 1989;339:61-64.
15. De Fougerolles AR, Stacker SA, Schwarting R, Springer TA. Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. J Exp Med. 1991;174:253-267.
16. Fawcett J, Holness CLL, Needham LA, et al. Molecular cloning of ICAM-3, a third ligand for LFA-1, constitutively expressed on resting leukocytes. Nature. 1992;360:481-484.
17. De Fougerolles AR, Springer TA. Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting lymphocytes. J Exp Med. 1992;175:185-190.
18. Altieri DC, Edgington TS. The saturable high affinity association of factor X to ADP-stimulated monocytes defines a novel function of the Mac-1 receptor. J Biol Chem. 1988;263:7007-7015.
19. Wright SD, Levin SM, Jong MT, Chad Z, Kabbash LG. CR3 (CD11b/CD18) expresses one binding site for Arg-Gly-Asp-containing peptides and a second site for bacterial lipopolysaccharide. J Exp Med. 1989;169:175-183.
20. Altieri DC, Agbanyo FR, Plescia J, et al. A unique recognition site mediates the interaction of fibrinogen with the leukocyte integrin Mac-1 (CD11b/CD18). J Biol Chem. 1990;265:12119-12122.
21. Diamond MS, Staunton DE, Marlin SD, Springer TA. Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell. 1991;65:961-971.
22. Bilsland CA, Diamond MS, Springer TA. The leukocyte integrin p150,95 (CD11c/CD18) as a receptor for iC3b: activation by a heterologous β subunit and localization of a ligand recognition site to the I domain. J Immunol. 1994;152:4582-4589.
23. Coombe DR, Watt SM, Parish CR. (CD11b/CD18) and CD45 mediate the adhesion of hematopoietic progenitor cells to stroma cell elements via recognition of stromal heparin sulfate. Blood. 1994;84:739-752.
24. Walzog B, Schuppan D, Heimpel C, et al. The leukocyte integrin Mac-1 (CD11b/CD18) contributes to binding of human granulocytes to collagen. Exp Cell Res. 1995;218:28-38.
25. Diamond MS, Alon R, Parkos CA, Quinn MT, Springer TA. Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11 b/CD18). J Cell Biol. 1995;130:1473-1482.
26. Stacker SA, Springer TA. Leukocyte integrin p150,95 (CD11c/CD18) functions as an adhesion molecule binding to a counter-receptor on stimulated endothelium. J Immunol. 1991;146:648-655.
27. Myones BL, Daizell JG, Hogg N, Ross GD. Neutrophil and monocyte cell surface p150,95 has iC3b-receptor (CR4) activity resembling CR3. J Clin Invest. 1988;82:640-651.
28. Loike JD, Sodeik B, Cao L, et al. CD11c/CD18 on neutrophils recognizes a domain at the N terminus of the A α chain of fibrinogen. Proc Natl Acad Sci U S A. 1991;88:1044-1048.
29. Ingalis RR, Golenbock DT. CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide. J Exp Med. 1995;181:1473-1479.
30. 2 integrin (CD11c-CD18, gp150,95). J Immunol. 2000;164:5928-5934.
31. Letellier M, Sarfati M, Delespesse G. Mechanisms of formation of IgE-BFs (soluble CD23). I. FcεRII bearing B cells generate IgE-binding factors of different molecular weights. Mol Immunol. 1989;26:1105-1112.
32. Aubry J-P, Pochon S, Graber P, Jansen KU, Bonnefoy J-Y. CD21 is a ligand for CD23 and regulated IgE production. Nature. 1992;358:505-507.
33. Bonnefoy JY, Aubry JP, Gauchat JF, et al. Receptors for IgE. Curr Opin Immunol. 1993;5:944-947.
34. Lecoanet-Henchoz S, Gauchat J-F, Aubry J-P, et al. CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18. Immunity. 1995;3:119-125.
35. Bonnefoy J-Y, Plater-Zyberk C, Lecoanet-Henchoz S, et al. A new role for CD23 in inflammation. Immunol Today. 1996;17:418-420.
36. Lecoanet-Henchoz S, Plater-Zyberk C, Graber P, et al. Mouse CD23 regulates monocyte activation through an interaction with the adhesion molecule CD11b/CD18. Eur J Immunol. 1997;27:22902294.
37. Aubry J-P, Dugas N, Lecoanet-Henchoz S, et al. The 25-kDa soluble CD23 activates type III constitutive nitric oxide-synthase activity via CD11b and CD11c expressed by human monocytes. J Immunol. 1997;159:614-622.
38. Fan ST, Edgington TS. Integrin regulation of leukocyte inflammatory functions: CD11b/CD18 enhancement of the tumor necrosis factor-α responses of monocytes. J Immunol. 1993;150:2972-2980.
39. Dackiw APB, Nathens AB, Marshall JC, Rotstein OD. Integrin engagement induces monocyte procoagulant activity and tumor necrosis factor production via induction of tyrosine phosphorylation. J Surg Res. 1996;64:210-215.
40. Yamada A, Hara A, Inoue M, et al. β2-integrin-mediated signal up-regulates counter-receptor ICAM-1 expression on human monocytic cell line THP-1 through tyrosine phosphorylation. Cell Immunol. 1997;178:9-16.
41. 2 integrin by antibodies or soluble CD23 induces IL-1β production on primary human monocytes through mitogen-activated protein kinase-dependent pathways. Blood. 2000;95:3868-3877.
42. Lukacs NW, Strieter RM, Elner V, et al. Intercellular adhesion molecule-1 mediates the expression of monocyte-derived MIP-1 α during monocyteendothelial cell interactions. Blood. 1994;83:1174-1178.
43. Lukacs NW, Strieter RM, Elner V, et al. Production of chemokines, interleukin-8 and monocyte chemoattractant protein-1, during monocyte:endothelial cell interactions. Blood. 1995;86:2767-2773.
44. Allet B, Bernard AR, Hochmann A, et al. A bacterial signal peptide directs efficient secretion of eukaryotic proteins in the baculovirus expression system. Protein Expr Purif. 1997;9:61-68.
45. Mentzer SJ, Guyre PM, Burakoff SJ, Faller DV. Spontaneous aggregation as a mechanism for human monocyte purification. Cell Immunol. 1986;101:312-319.
46. Duff GW, Atkins E. The inhibitory effect of polymyxin B on endotoxin-induced endogenous pyrogen production. J Immunol Methods. 1982;52:333-340.
47. Schreiber E, Matthias P, Müller MM, Schaffner W. Rapid detection of octamer binding proteins with "mini-extracts" prepared from a small number of cells. Nucleic Acids Res. 1989;17:6419.
48. Armant M, Rubio M, Delespesse G, Sarfati M. Soluble CD23 directly activates monocytes to contribute to the antigen-independent stimulation of resting T cells. J Immunol. 1995;155:4868-4875.
49. Taub DD, Oppenheim JJ. Chemokines, inflammation and the immune system. Ther Immunol. 1994;1:229-246.
50. Juliano RL, Haskill S. Signal transduction from the extracellular matrix. J Cell Biol. 1993;120:577-585.
51. Smith RE, Strieter RM, Phan SH, Lukacs N, Kunkel SL. TNF and IL-6 mediate MIP-1α expression in bleomycin-induced lung injury. J Leukoc Biol. 1998;64:528-536.
52. Taichman RS, Reilly MJ, Matthews LS. Human osteoblast-like cells and osteosarcoma cell lines synthesize macrophage inhibitory protein 1α in response to interleukin 1β and tumour necrosis factor α stimulation in vitro. Br J Haematol. 2000;108:275-283.
53. Grove M, Plumb M. C/EBP, NF-κB and c-Ets family members and transcriptional regulation of the cell-specific and inducible macrophage inflammatory protein 1α immediate-early gene. Mol Cell Biol. 1993;13:5276-5289.
54. Henkel T, Machleidt T, Alkalay I, et al. Rapid proteolysis of IκB-α is necessary for activation of transcription factor NFκB. Nature. 1993;365:182-185.
55. KB1 precursor protein and the activation of NFκB. Cell. 1994;78:773-785.
56. Alkalay I, Yaron A, Hatzubai A, et al. Stimulation-dependent IκB-α phosphorylation marks the NF-κB inhibitor for degradation via the ubiquitin-proteasome pathway. Proc. Natl Acad Sci U S A. 1995;92:10599-10603.
57. Baldwin AS. The NFκB and IκB proteins: new discoveries and insights. Annu Rev Immunol. 1996;14:649-681.
58. Sun S-C, Ganchi PA, Ballard DW, Greene WC. NF-κB controls expression of inhibitor IκB-α: evidence for an inducible autoregulatory pathway. Science. 1993;259:1912-1915.
59. Traenckner EB-M, Wilk S, Bauerle PA. A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκB-α that is still bound to NF-κB. EMBO J. 1994;13:5433-5441.
60. Schow SR, Joly A. N-Acetyl-leucinyl-leucinyl-norleucinal inhibits lipopolysacchadde-induced NF-κB activation and prevents TNF and IL-6 synthesis in vivo. Cell Immunol. 1997;175:199-202.
61. Imbert V, Rupec RA, Livolsi A, et al. Tyrosine phosphorylation of IκB-α activates NF-κB without proteolytic degradation of IκB-α. Cell. 1996;86:787-798.
62. Detmers PA, Lo SK, Olsen-Egbert E, et al. Neutrophil-activating protein 1/IL-8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils. J Exp Med. 1990;171:1155-1162.
63. 2 integrins lymphocyte function-associated antigen-1 and Mac-1 by chemokines mediated by distinct pathways via the α subunit cytoplasmic domains. Mol Biol Cell. 1999;10:861-873.
64. Lukacs NW, Chensue SW, Smith RE, et al. Production of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 α by inflammatory granuloma fibroblasts. Am J Pathol. 1994;144:711-718.
65. Weyrich AS, Elstad MR, McEver RP, et al. Activated platelets signal chemokine synthesis by human monocytes. J Ciin invest. 1996;97:1525-1534.
66. Zickus C, Kunkel SL, Simpson K, et al. Differential regulation of C-C chemokines during fibroblast-monocyte interactions: adhesion vs inflammatory cytokine pathways. Mediators Inflamm. 1998;7:269-274.
67. Steinhauser ML, Kunkel SL, Hogaboam CM, et al. Macrophage/fibroblast coculture induces macrophage inflammatory protein-1 α production mediated by intercellular adhesion molecule-1 and oxygen radicals. J Leukoc Biol. 1998;64:636-641.
68. 2 integrins (CD11/CD18) in the regulation of cytokine gene expression of polymorphonuclear neutrophils during the inflammatory response. FASEB J. 1999;13:1855-1865.
69. VanOtteren GM, Standiford TJ, Kunkel SL, et al. Expression and regulation of macrophage inflammatory protein-1 α by murine alveolar and peritoneal macrophages. Am J Respir Cell Mol Biol. 1994;10:8-15.
70. 2D3 induce on THP-1 cells distinct patterns of cell surface antigen expression, cytokine production and responsiveness to contact with activated T cells. J Immunol. 1992;149:2040-2046.
71. Isler P, Vey E, Zhang JH, Dayer JM. Cell surface glycoproteins expressed on activated human T cells induce production of interleukin-1 β by monocytic cells: a possible role of CD69. Eur Cytokine Netw. 1993;4:15-23.
72. Armant M, Ishihara H, Rubio M, Delespesse G, Sarfati M. Regulation of cytokine production by soluble CD23: costimulation of interferon γ secretion and triggering of tumor necrosis factor α release. J Exp Med. 1994;180:1005-1011.
73. Kunsch C, Rosen CA. NF-κB subunit-specific regulation of the interleukin-8 promoter. Mol Cell Biol. 1993;13:6137-6146.
74. Sitrin RG, Pan PM, Srikanth S, Todd RF III. Fibrinogen activates NF-κB transcription factors in mononuclear phagocytes. J Immunol. 1998;161:1462-1470.
75. Haas M, Page S, Page M, et al. Effect of proteasome inhibitors on monocytic IκB-α and -β depletion, NF-κB activation, and cytokine production. J Leukoc Biol. 1998;63:395-404.
76. Koch AE, Kunkel SL, Harlow LA, et al. Macrophage inflammatory protein-1 α: a novel chemotactic cytokine for macrophages in rheumatoid arthritis. J Clin Invest. 1994;93:921-928.
77. Koch AE, Kunkel SL, Shah MR, et al. Macrophage inflammatory protein-1 β: a C-C chemokine in osteoarthritis. Clin Immunol Immunopathol. 1995;77:307-314.
78. Fuller K, Owens JM, Chambers TJ. Macrophage inflammatory protein-1 α and IL-8 stimulate the motility but suppress the resorption of isolated rat osteoclasts. J Immunol. 1995;154:6065-6072.
79. Chomarat P, Briolay J, Banchereau J, Miossec P. Increased production of soluble CD23 in rheumatoid arthritis, and its regulation by interleukin-4. Arthritis Rheum. 1993;36:234-242.
80. Huissoon AP, Emery P, Bacon PA, Gordon J, Salmon M. Increased expression of CD23 in rheumatoid synovitis. Scand J Rheumatol. 2000;29:154-159.
81. Ribbens C, Bonnet V, Kaiser MJ, et al. Increased synovial fluid levels of soluble CD23 are associated with an erosive status in rheumatoid arthritis (RA). Clin Exp Immunol. 2000;120:194-199.
82. Torsteinsdottir I, Arvidson NG, Hallgren R, Hakansson L. Monocyte activation in rheumatoid arthritis (RA): increased integrin, Fc gamma and complement receptor expression and the effect of glucocorticoids. Clin Exp Immunol. 1999;115:554-560.
83. Baggiolini M, Moser B. Blocking chemokine receptors. J Exp Med. 1997;186:1189-1191.
84. Cornejo CJ, Winn RK, Harlan JM. Anti-adhesion therapy. Adv Pharmacol. 1997;39:99-142.
85. Diaz-Gonzalez F, Sanchez-Madrid F. Inhibition of leukocyte adhesion: an alternative mechanism of action for anti-inflammatory drugs. Immunol Today. 1998;19:169-172.
86. Foxwell BMJ, Browne KA, Bondeson J, et al. Efficient adenoviral infection with IκB α reveals that macrophage tumor necrosis factor α production in rheumatoid arthritis is NF-κB dependent. Proc Natl Acad Sci U S A. 1998;95:8211-8215.
87. Bondeson J, Browne KA, Brennan FM, Foxwell BMJ, Feldmann M. Selective regulation of cytokine induction by adenoviral gene transfer of IκBα into human macrophages: lipopolysaccharide-induced, but not zymosan-induced, proinflammatory cytokines are inhibited, but IL-10 is nuclear factor-κB independent. J Immunol. 1999;162:2939-2945.
88. Bondeson J, Foxwell BMJ, Brennan FM, Feldmann M. Defining therapeutic targets by using adenovirus: blocking NF-κB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators. Proc Natl Acad Sci U S A. 1999;96:5668-5673.